Stephen Daniel Bacchi, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Natural Language Processing | 16 | 2024 | 1203 | 3.500 |
Why?
|
Artificial Intelligence | 19 | 2024 | 2659 | 3.260 |
Why?
|
Australia | 30 | 2024 | 1258 | 2.750 |
Why?
|
Ophthalmology | 12 | 2024 | 561 | 1.850 |
Why?
|
Rural Health Services | 7 | 2024 | 393 | 1.700 |
Why?
|
Penicillins | 6 | 2024 | 404 | 1.660 |
Why?
|
Stroke | 15 | 2024 | 9747 | 1.650 |
Why?
|
Patient Discharge | 9 | 2024 | 3461 | 1.600 |
Why?
|
Students, Medical | 9 | 2024 | 1959 | 1.560 |
Why?
|
Myasthenia Gravis | 4 | 2023 | 214 | 1.510 |
Why?
|
Electronic Health Records | 13 | 2024 | 4873 | 1.310 |
Why?
|
Drug Hypersensitivity | 4 | 2024 | 902 | 1.150 |
Why?
|
Length of Stay | 8 | 2024 | 6485 | 1.080 |
Why?
|
Illusions | 2 | 2024 | 62 | 1.070 |
Why?
|
Vital Signs | 2 | 2024 | 147 | 1.000 |
Why?
|
Inpatients | 7 | 2024 | 2564 | 0.970 |
Why?
|
Delayed Graft Function | 1 | 2024 | 50 | 0.910 |
Why?
|
Hypersensitivity | 5 | 2023 | 1168 | 0.900 |
Why?
|
Humans | 179 | 2025 | 765968 | 0.890 |
Why?
|
Resuscitation Orders | 2 | 2024 | 275 | 0.880 |
Why?
|
Brain Ischemia | 6 | 2023 | 3000 | 0.860 |
Why?
|
Workflow | 3 | 2024 | 862 | 0.840 |
Why?
|
Cardiopulmonary Resuscitation | 4 | 2024 | 1002 | 0.840 |
Why?
|
Hygiene | 1 | 2023 | 95 | 0.810 |
Why?
|
Hospitals, Rural | 1 | 2024 | 175 | 0.800 |
Why?
|
Licensure | 1 | 2023 | 128 | 0.800 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2023 | 669 | 0.780 |
Why?
|
General Practice | 1 | 2023 | 102 | 0.780 |
Why?
|
South Australia | 7 | 2024 | 27 | 0.760 |
Why?
|
Guillain-Barre Syndrome | 1 | 2023 | 128 | 0.750 |
Why?
|
Consciousness | 3 | 2023 | 601 | 0.750 |
Why?
|
Environment | 2 | 2024 | 1114 | 0.740 |
Why?
|
Unconsciousness | 1 | 2023 | 250 | 0.740 |
Why?
|
Valproic Acid | 1 | 2024 | 445 | 0.730 |
Why?
|
Documentation | 2 | 2024 | 916 | 0.720 |
Why?
|
Computers | 1 | 2023 | 588 | 0.710 |
Why?
|
Hematinics | 1 | 2023 | 282 | 0.690 |
Why?
|
Resilience, Psychological | 2 | 2020 | 806 | 0.680 |
Why?
|
Risk Management | 1 | 2023 | 559 | 0.670 |
Why?
|
Clinical Coding | 1 | 2021 | 190 | 0.670 |
Why?
|
Anaphylaxis | 2 | 2024 | 739 | 0.640 |
Why?
|
Arterial Occlusive Diseases | 1 | 2023 | 729 | 0.620 |
Why?
|
Renal Dialysis | 2 | 2024 | 1799 | 0.600 |
Why?
|
Epilepsy | 2 | 2024 | 3320 | 0.590 |
Why?
|
Food | 1 | 2023 | 764 | 0.590 |
Why?
|
Patient Readmission | 5 | 2024 | 3286 | 0.580 |
Why?
|
Rural Population | 4 | 2024 | 2317 | 0.580 |
Why?
|
Ischemic Attack, Transient | 2 | 2023 | 870 | 0.570 |
Why?
|
Delivery of Health Care | 3 | 2024 | 5370 | 0.570 |
Why?
|
LDL-Receptor Related Proteins | 1 | 2018 | 118 | 0.570 |
Why?
|
Hypotension, Orthostatic | 2 | 2019 | 257 | 0.560 |
Why?
|
Algorithms | 11 | 2024 | 14071 | 0.560 |
Why?
|
Domperidone | 1 | 2017 | 24 | 0.550 |
Why?
|
Peripheral Nervous System Diseases | 1 | 2023 | 712 | 0.550 |
Why?
|
Hand | 1 | 2022 | 909 | 0.550 |
Why?
|
Neurosurgical Procedures | 3 | 2023 | 2074 | 0.550 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2017 | 82 | 0.540 |
Why?
|
Defibrillators | 4 | 2023 | 39 | 0.540 |
Why?
|
Checklist | 1 | 2024 | 848 | 0.540 |
Why?
|
Glucocorticoids | 3 | 2024 | 2132 | 0.520 |
Why?
|
Physical Examination | 1 | 2022 | 1266 | 0.520 |
Why?
|
Cerebrovascular Disorders | 2 | 2023 | 1470 | 0.520 |
Why?
|
Students | 3 | 2023 | 1734 | 0.510 |
Why?
|
Dopamine Antagonists | 1 | 2017 | 278 | 0.510 |
Why?
|
New Zealand | 6 | 2024 | 359 | 0.480 |
Why?
|
Hospital Mortality | 4 | 2024 | 5343 | 0.480 |
Why?
|
Out-of-Hospital Cardiac Arrest | 3 | 2023 | 340 | 0.480 |
Why?
|
Education, Medical | 3 | 2024 | 1746 | 0.470 |
Why?
|
Statistics as Topic | 1 | 2021 | 2352 | 0.460 |
Why?
|
Forecasting | 2 | 2021 | 2936 | 0.450 |
Why?
|
Seizures | 2 | 2024 | 3000 | 0.450 |
Why?
|
Anticonvulsants | 1 | 2024 | 1921 | 0.440 |
Why?
|
Pilot Projects | 9 | 2024 | 8733 | 0.440 |
Why?
|
Retrospective Studies | 30 | 2024 | 81514 | 0.440 |
Why?
|
Education, Medical, Undergraduate | 2 | 2024 | 1085 | 0.420 |
Why?
|
Perioperative Period | 2 | 2024 | 251 | 0.420 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2592 | 0.410 |
Why?
|
Stress, Psychological | 2 | 2020 | 4533 | 0.410 |
Why?
|
Nervous System Diseases | 1 | 2023 | 1660 | 0.400 |
Why?
|
Aortic Valve Stenosis | 1 | 2025 | 2023 | 0.400 |
Why?
|
Endovascular Procedures | 3 | 2024 | 2222 | 0.390 |
Why?
|
Palliative Care | 2 | 2024 | 3645 | 0.390 |
Why?
|
Hospitalization | 5 | 2023 | 10808 | 0.370 |
Why?
|
Curriculum | 6 | 2024 | 3782 | 0.370 |
Why?
|
Specialties, Surgical | 3 | 2024 | 391 | 0.360 |
Why?
|
General Surgery | 5 | 2024 | 1722 | 0.340 |
Why?
|
Kidney Transplantation | 1 | 2024 | 4270 | 0.320 |
Why?
|
Autoantibodies | 1 | 2018 | 2113 | 0.320 |
Why?
|
Magnetic Resonance Imaging | 7 | 2024 | 36532 | 0.310 |
Why?
|
Aged | 24 | 2024 | 171117 | 0.300 |
Why?
|
Thrombectomy | 3 | 2024 | 681 | 0.300 |
Why?
|
Electroencephalography | 1 | 2024 | 6273 | 0.300 |
Why?
|
Periodicals as Topic | 3 | 2024 | 1462 | 0.300 |
Why?
|
Atrial Fibrillation | 3 | 2023 | 5189 | 0.290 |
Why?
|
Area Under Curve | 3 | 2021 | 1638 | 0.280 |
Why?
|
Databases, Bibliographic | 2 | 2018 | 128 | 0.270 |
Why?
|
Registries | 1 | 2023 | 8297 | 0.270 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2019 | 3356 | 0.270 |
Why?
|
Educational Measurement | 2 | 2024 | 1260 | 0.260 |
Why?
|
Parkinson Disease | 2 | 2019 | 2895 | 0.260 |
Why?
|
Cultural Diversity | 3 | 2024 | 370 | 0.260 |
Why?
|
Time Factors | 7 | 2024 | 40065 | 0.260 |
Why?
|
Medicare | 2 | 2023 | 6823 | 0.250 |
Why?
|
Middle Aged | 21 | 2024 | 223009 | 0.250 |
Why?
|
Physicians | 1 | 2023 | 4588 | 0.250 |
Why?
|
Telemedicine | 1 | 2023 | 3105 | 0.250 |
Why?
|
Vitreoretinal Surgery | 1 | 2024 | 28 | 0.230 |
Why?
|
Anticoagulants | 4 | 2023 | 4862 | 0.230 |
Why?
|
Food Service, Hospital | 1 | 2024 | 18 | 0.230 |
Why?
|
Male | 28 | 2024 | 363698 | 0.230 |
Why?
|
Glioma | 1 | 2019 | 3493 | 0.230 |
Why?
|
Camelids, New World | 1 | 2024 | 20 | 0.230 |
Why?
|
Surgical Wound Infection | 2 | 2023 | 1543 | 0.220 |
Why?
|
Universal Precautions | 1 | 2023 | 34 | 0.220 |
Why?
|
Rheumatic Fever | 1 | 2024 | 73 | 0.220 |
Why?
|
Intubation | 1 | 2024 | 141 | 0.220 |
Why?
|
Cerebrospinal Fluid Proteins | 1 | 2023 | 71 | 0.220 |
Why?
|
Authorship | 2 | 2023 | 288 | 0.220 |
Why?
|
Female | 27 | 2024 | 396112 | 0.220 |
Why?
|
Electric Countershock | 2 | 2023 | 534 | 0.210 |
Why?
|
Reperfusion | 1 | 2024 | 267 | 0.210 |
Why?
|
Medical Audit | 1 | 2024 | 452 | 0.210 |
Why?
|
Tramadol | 1 | 2023 | 63 | 0.210 |
Why?
|
Surgery Department, Hospital | 1 | 2024 | 170 | 0.210 |
Why?
|
Decompressive Craniectomy | 1 | 2023 | 76 | 0.200 |
Why?
|
Rural Health | 1 | 2024 | 301 | 0.200 |
Why?
|
Risk Factors | 12 | 2025 | 74840 | 0.200 |
Why?
|
Respiratory Rate | 1 | 2024 | 179 | 0.200 |
Why?
|
Rheumatic Heart Disease | 1 | 2024 | 165 | 0.200 |
Why?
|
Food Handling | 1 | 2023 | 158 | 0.200 |
Why?
|
Injections, Subcutaneous | 1 | 2024 | 682 | 0.200 |
Why?
|
Dupuytren Contracture | 1 | 2023 | 66 | 0.200 |
Why?
|
Hematologic Tests | 1 | 2023 | 239 | 0.200 |
Why?
|
Aerospace Medicine | 1 | 2023 | 95 | 0.200 |
Why?
|
Triage | 2 | 2019 | 996 | 0.200 |
Why?
|
Methylprednisolone | 1 | 2023 | 386 | 0.200 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 194 | 0.190 |
Why?
|
Linguistics | 1 | 2022 | 110 | 0.190 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2023 | 239 | 0.190 |
Why?
|
Basilar Artery | 1 | 2023 | 206 | 0.190 |
Why?
|
Breath Tests | 1 | 2023 | 297 | 0.190 |
Why?
|
Blepharoptosis | 1 | 2023 | 143 | 0.190 |
Why?
|
Anti-Bacterial Agents | 4 | 2024 | 7478 | 0.190 |
Why?
|
Antiemetics | 1 | 2023 | 185 | 0.190 |
Why?
|
Prognosis | 3 | 2024 | 29922 | 0.190 |
Why?
|
Optic Neuropathy, Ischemic | 1 | 2023 | 87 | 0.190 |
Why?
|
Emergency Medical Services | 2 | 2023 | 1938 | 0.190 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6547 | 0.190 |
Why?
|
Optic Neuritis | 1 | 2023 | 172 | 0.190 |
Why?
|
Adrenal Glands | 1 | 2024 | 558 | 0.190 |
Why?
|
Anti-Infective Agents, Local | 1 | 2023 | 245 | 0.180 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2019 | 9373 | 0.180 |
Why?
|
Cultural Competency | 1 | 2024 | 303 | 0.180 |
Why?
|
Vasospasm, Intracranial | 1 | 2023 | 206 | 0.180 |
Why?
|
Costs and Cost Analysis | 2 | 2023 | 1668 | 0.180 |
Why?
|
Preoperative Care | 3 | 2024 | 2267 | 0.180 |
Why?
|
Marketing | 1 | 2022 | 225 | 0.170 |
Why?
|
Intensive Care Units | 2 | 2024 | 3800 | 0.170 |
Why?
|
Epinephrine | 1 | 2024 | 783 | 0.170 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 2024 | 497 | 0.170 |
Why?
|
Depression | 2 | 2023 | 8237 | 0.170 |
Why?
|
Vitrectomy | 1 | 2023 | 389 | 0.170 |
Why?
|
Blood Glucose | 2 | 2024 | 6424 | 0.170 |
Why?
|
Macular Edema | 1 | 2024 | 387 | 0.170 |
Why?
|
Spirometry | 1 | 2023 | 929 | 0.170 |
Why?
|
Patients' Rooms | 1 | 2020 | 63 | 0.160 |
Why?
|
Patients | 2 | 2023 | 910 | 0.160 |
Why?
|
Thyrotropin | 1 | 2023 | 841 | 0.160 |
Why?
|
Waiting Lists | 1 | 2024 | 777 | 0.160 |
Why?
|
Publishing | 2 | 2024 | 835 | 0.160 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2023 | 614 | 0.160 |
Why?
|
Language | 3 | 2024 | 1550 | 0.160 |
Why?
|
Risk Assessment | 5 | 2025 | 24282 | 0.160 |
Why?
|
Cross-Sectional Studies | 5 | 2024 | 26318 | 0.160 |
Why?
|
Giant Cell Arteritis | 1 | 2023 | 302 | 0.160 |
Why?
|
Optic Nerve Diseases | 1 | 2023 | 343 | 0.160 |
Why?
|
Pain, Postoperative | 3 | 2024 | 1772 | 0.160 |
Why?
|
Postoperative Complications | 6 | 2024 | 15747 | 0.160 |
Why?
|
Students, Nursing | 1 | 2019 | 46 | 0.160 |
Why?
|
Databases, Factual | 3 | 2024 | 8067 | 0.160 |
Why?
|
Referral and Consultation | 2 | 2024 | 3615 | 0.160 |
Why?
|
Cataract Extraction | 1 | 2023 | 464 | 0.160 |
Why?
|
Training Support | 1 | 2019 | 109 | 0.160 |
Why?
|
Reading | 1 | 2022 | 539 | 0.150 |
Why?
|
Serotonin | 1 | 2023 | 1049 | 0.150 |
Why?
|
Conflict of Interest | 1 | 2023 | 556 | 0.150 |
Why?
|
Vitiligo | 1 | 2019 | 96 | 0.150 |
Why?
|
Food Supply | 1 | 2024 | 544 | 0.150 |
Why?
|
Eye Diseases | 2 | 2024 | 659 | 0.150 |
Why?
|
Brain Neoplasms | 1 | 2019 | 9071 | 0.150 |
Why?
|
Hyperlipidemias | 1 | 2023 | 770 | 0.150 |
Why?
|
Malnutrition | 1 | 2024 | 629 | 0.150 |
Why?
|
History, 21st Century | 1 | 2024 | 1574 | 0.150 |
Why?
|
Health Literacy | 1 | 2023 | 464 | 0.150 |
Why?
|
Schools, Medical | 2 | 2024 | 876 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2023 | 962 | 0.140 |
Why?
|
Hearing Loss, Sensorineural | 1 | 2023 | 781 | 0.140 |
Why?
|
Endarterectomy, Carotid | 1 | 2022 | 557 | 0.140 |
Why?
|
Treatment Outcome | 9 | 2024 | 65188 | 0.140 |
Why?
|
Hypoglycemia | 1 | 2024 | 896 | 0.140 |
Why?
|
Terminology as Topic | 1 | 2024 | 1534 | 0.140 |
Why?
|
Hydrocephalus | 1 | 2023 | 762 | 0.140 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 705 | 0.140 |
Why?
|
Carotid Artery Diseases | 1 | 2023 | 874 | 0.130 |
Why?
|
Appendicitis | 1 | 2023 | 679 | 0.130 |
Why?
|
Tomography, Optical Coherence | 3 | 2024 | 2932 | 0.130 |
Why?
|
False Positive Reactions | 1 | 2019 | 955 | 0.130 |
Why?
|
Reference Values | 1 | 2023 | 4908 | 0.130 |
Why?
|
History, 20th Century | 1 | 2024 | 2761 | 0.130 |
Why?
|
Information Storage and Retrieval | 1 | 2022 | 834 | 0.130 |
Why?
|
Adult | 13 | 2024 | 223044 | 0.130 |
Why?
|
Infarction, Middle Cerebral Artery | 1 | 2019 | 485 | 0.130 |
Why?
|
Otolaryngology | 1 | 2023 | 698 | 0.130 |
Why?
|
Cooperative Behavior | 1 | 2023 | 1509 | 0.130 |
Why?
|
Hyperglycemia | 1 | 2024 | 1393 | 0.130 |
Why?
|
Evidence-Based Medicine | 2 | 2024 | 3685 | 0.130 |
Why?
|
Macular Degeneration | 1 | 2023 | 1014 | 0.120 |
Why?
|
Universities | 2 | 2023 | 998 | 0.120 |
Why?
|
Aged, 80 and over | 6 | 2024 | 59489 | 0.120 |
Why?
|
Carotid Stenosis | 1 | 2022 | 861 | 0.120 |
Why?
|
Intubation, Intratracheal | 1 | 2023 | 1303 | 0.120 |
Why?
|
Vascular Surgical Procedures | 1 | 2024 | 1485 | 0.120 |
Why?
|
Aortic Valve | 1 | 2025 | 1968 | 0.120 |
Why?
|
Internationality | 1 | 2020 | 1007 | 0.120 |
Why?
|
Thrombolytic Therapy | 2 | 2024 | 2059 | 0.110 |
Why?
|
Sulfonamides | 1 | 2024 | 1984 | 0.110 |
Why?
|
Patient Education as Topic | 1 | 2024 | 2334 | 0.110 |
Why?
|
Neuroma, Acoustic | 1 | 2018 | 456 | 0.110 |
Why?
|
Leadership | 1 | 2023 | 1392 | 0.110 |
Why?
|
Prospective Studies | 7 | 2024 | 54802 | 0.110 |
Why?
|
Cause of Death | 1 | 2025 | 3708 | 0.110 |
Why?
|
Automobile Driving | 1 | 2019 | 441 | 0.110 |
Why?
|
Psychology | 1 | 2016 | 354 | 0.110 |
Why?
|
Neurodegenerative Diseases | 1 | 2023 | 1087 | 0.110 |
Why?
|
Orthopedics | 1 | 2023 | 900 | 0.110 |
Why?
|
Biomedical Research | 3 | 2024 | 3458 | 0.110 |
Why?
|
Risk-Taking | 1 | 2019 | 1021 | 0.110 |
Why?
|
Graft Survival | 1 | 2024 | 3890 | 0.110 |
Why?
|
Software | 3 | 2022 | 4462 | 0.110 |
Why?
|
Dermatology | 1 | 2023 | 907 | 0.110 |
Why?
|
Feasibility Studies | 1 | 2024 | 5302 | 0.110 |
Why?
|
School Admission Criteria | 2 | 2024 | 106 | 0.110 |
Why?
|
Logistic Models | 3 | 2024 | 13266 | 0.100 |
Why?
|
ROC Curve | 1 | 2021 | 3620 | 0.100 |
Why?
|
Internship and Residency | 2 | 2024 | 5946 | 0.100 |
Why?
|
Kidney Diseases | 1 | 2024 | 2098 | 0.100 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2024 | 2136 | 0.100 |
Why?
|
Patient Care Team | 1 | 2024 | 2517 | 0.100 |
Why?
|
Hospitals | 2 | 2024 | 3888 | 0.100 |
Why?
|
Career Choice | 1 | 2019 | 769 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2023 | 1458 | 0.100 |
Why?
|
Sleep Deprivation | 1 | 2019 | 845 | 0.100 |
Why?
|
Wound Healing | 1 | 2023 | 2792 | 0.100 |
Why?
|
Heart Rate | 1 | 2024 | 4204 | 0.100 |
Why?
|
Respiration, Artificial | 1 | 2023 | 2709 | 0.090 |
Why?
|
Outpatients | 1 | 2019 | 1595 | 0.090 |
Why?
|
Sleep | 2 | 2024 | 4813 | 0.090 |
Why?
|
Cardiac Surgical Procedures | 2 | 2024 | 3675 | 0.090 |
Why?
|
Clinical Competence | 2 | 2024 | 4863 | 0.090 |
Why?
|
Administration, Oral | 3 | 2023 | 4015 | 0.090 |
Why?
|
Hip Fractures | 1 | 2019 | 997 | 0.090 |
Why?
|
Analgesics, Opioid | 2 | 2024 | 3835 | 0.090 |
Why?
|
Ventricular Function, Left | 1 | 2024 | 3928 | 0.090 |
Why?
|
Hemorrhage | 1 | 2023 | 3461 | 0.090 |
Why?
|
Internet | 1 | 2023 | 3106 | 0.090 |
Why?
|
Deep Brain Stimulation | 1 | 2019 | 850 | 0.090 |
Why?
|
Survival Rate | 1 | 2025 | 12795 | 0.090 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 1560 | 0.090 |
Why?
|
Headache | 1 | 2018 | 1259 | 0.080 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1882 | 0.080 |
Why?
|
Vitamin D | 1 | 2023 | 3272 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3213 | 0.080 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2018 | 2024 | 0.080 |
Why?
|
Health Services Accessibility | 2 | 2023 | 5508 | 0.080 |
Why?
|
Demography | 2 | 2024 | 1641 | 0.080 |
Why?
|
Diagnosis, Differential | 1 | 2024 | 12976 | 0.080 |
Why?
|
Death, Sudden, Cardiac | 1 | 2017 | 1568 | 0.080 |
Why?
|
Cohort Studies | 4 | 2024 | 41649 | 0.080 |
Why?
|
Life Style | 1 | 2020 | 3926 | 0.080 |
Why?
|
Tachycardia, Ventricular | 1 | 2017 | 1310 | 0.070 |
Why?
|
Education, Medical, Graduate | 3 | 2024 | 2418 | 0.070 |
Why?
|
Pain | 1 | 2022 | 5077 | 0.070 |
Why?
|
Disease Progression | 1 | 2024 | 13632 | 0.070 |
Why?
|
Arrhythmias, Cardiac | 1 | 2017 | 2247 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2024 | 15398 | 0.070 |
Why?
|
Graft vs Host Disease | 1 | 2019 | 3078 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2023 | 14652 | 0.070 |
Why?
|
United States | 3 | 2023 | 72903 | 0.060 |
Why?
|
Educational Status | 2 | 2023 | 2513 | 0.060 |
Why?
|
Depressive Disorder, Major | 1 | 2023 | 4808 | 0.060 |
Why?
|
Mental Health | 1 | 2019 | 3278 | 0.060 |
Why?
|
Skin Neoplasms | 1 | 2024 | 5849 | 0.060 |
Why?
|
Primary Health Care | 1 | 2021 | 4736 | 0.060 |
Why?
|
Vitreous Detachment | 1 | 2024 | 22 | 0.060 |
Why?
|
Visual Acuity | 2 | 2024 | 2708 | 0.060 |
Why?
|
Neoplasms | 2 | 2023 | 22340 | 0.060 |
Why?
|
Serotonin 5-HT3 Receptor Antagonists | 1 | 2023 | 23 | 0.050 |
Why?
|
Povidone-Iodine | 1 | 2023 | 54 | 0.050 |
Why?
|
Nimodipine | 1 | 2023 | 56 | 0.050 |
Why?
|
2-Propanol | 1 | 2023 | 28 | 0.050 |
Why?
|
Prone Position | 1 | 2024 | 201 | 0.050 |
Why?
|
Depth Perception | 1 | 2023 | 94 | 0.050 |
Why?
|
Hypertension | 1 | 2023 | 8626 | 0.050 |
Why?
|
New South Wales | 1 | 2023 | 69 | 0.050 |
Why?
|
Sunscreening Agents | 1 | 2024 | 138 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6544 | 0.050 |
Why?
|
Surgical Procedures, Operative | 2 | 2024 | 1941 | 0.050 |
Why?
|
Journal Impact Factor | 1 | 2024 | 157 | 0.050 |
Why?
|
Collagenases | 1 | 2023 | 221 | 0.050 |
Why?
|
Verapamil | 1 | 2023 | 242 | 0.050 |
Why?
|
Carbamazepine | 1 | 2023 | 222 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2024 | 20659 | 0.050 |
Why?
|
Personnel Selection | 1 | 2024 | 201 | 0.050 |
Why?
|
Hospitals, Public | 1 | 2024 | 203 | 0.050 |
Why?
|
Oxycodone | 1 | 2023 | 143 | 0.050 |
Why?
|
Vitreous Body | 1 | 2024 | 400 | 0.050 |
Why?
|
Ukraine | 1 | 2022 | 151 | 0.050 |
Why?
|
Publication Bias | 1 | 2022 | 158 | 0.050 |
Why?
|
Bandages | 1 | 2023 | 269 | 0.050 |
Why?
|
Ophthalmic Solutions | 1 | 2023 | 312 | 0.050 |
Why?
|
Russia | 1 | 2022 | 383 | 0.050 |
Why?
|
Systole | 1 | 2024 | 935 | 0.050 |
Why?
|
Health Occupations | 1 | 2023 | 226 | 0.050 |
Why?
|
Odds Ratio | 2 | 2024 | 9649 | 0.050 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2019 | 5753 | 0.050 |
Why?
|
Electronics | 1 | 2022 | 314 | 0.050 |
Why?
|
Pharynx | 1 | 2023 | 436 | 0.040 |
Why?
|
Bibliometrics | 1 | 2024 | 357 | 0.040 |
Why?
|
Nausea | 1 | 2023 | 680 | 0.040 |
Why?
|
Glucagon-Like Peptide 1 | 1 | 2023 | 373 | 0.040 |
Why?
|
Vasoconstriction | 1 | 2023 | 594 | 0.040 |
Why?
|
Thinness | 1 | 2023 | 482 | 0.040 |
Why?
|
Cost-Benefit Analysis | 2 | 2023 | 5526 | 0.040 |
Why?
|
National Health Programs | 1 | 2023 | 443 | 0.040 |
Why?
|
Communication Barriers | 1 | 2023 | 418 | 0.040 |
Why?
|
Delayed Diagnosis | 1 | 2023 | 452 | 0.040 |
Why?
|
Nose | 1 | 2023 | 519 | 0.040 |
Why?
|
Leukocyte Count | 1 | 2023 | 1602 | 0.040 |
Why?
|
Video Recording | 1 | 2024 | 969 | 0.040 |
Why?
|
Confidentiality | 1 | 2023 | 607 | 0.040 |
Why?
|
Frail Elderly | 1 | 2024 | 785 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2023 | 12240 | 0.040 |
Why?
|
Prednisone | 1 | 2023 | 1565 | 0.040 |
Why?
|
Automation | 1 | 2021 | 585 | 0.040 |
Why?
|
Sample Size | 1 | 2022 | 845 | 0.040 |
Why?
|
Medical Staff, Hospital | 1 | 2023 | 601 | 0.040 |
Why?
|
Veins | 1 | 2023 | 764 | 0.040 |
Why?
|
Netherlands | 1 | 2023 | 2277 | 0.040 |
Why?
|
Peer Group | 1 | 2024 | 701 | 0.040 |
Why?
|
Globus Pallidus | 1 | 2019 | 248 | 0.040 |
Why?
|
Retinal Diseases | 1 | 2024 | 709 | 0.040 |
Why?
|
Syndrome | 1 | 2024 | 3271 | 0.040 |
Why?
|
Angiography | 1 | 2023 | 1581 | 0.040 |
Why?
|
Canada | 1 | 2023 | 2119 | 0.040 |
Why?
|
Fluorescein Angiography | 1 | 2023 | 1085 | 0.040 |
Why?
|
Gastrointestinal Tract | 1 | 2023 | 834 | 0.040 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15652 | 0.030 |
Why?
|
Benzodiazepines | 1 | 2023 | 1136 | 0.030 |
Why?
|
Retinal Vessels | 1 | 2023 | 863 | 0.030 |
Why?
|
Cisplatin | 1 | 2023 | 1658 | 0.030 |
Why?
|
Photic Stimulation | 1 | 2023 | 1993 | 0.030 |
Why?
|
Informed Consent | 1 | 2023 | 1010 | 0.030 |
Why?
|
Geriatric Assessment | 1 | 2024 | 1429 | 0.030 |
Why?
|
Europe | 1 | 2023 | 3423 | 0.030 |
Why?
|
Subthalamic Nucleus | 1 | 2019 | 203 | 0.030 |
Why?
|
Nutritional Status | 1 | 2024 | 1620 | 0.030 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2023 | 10383 | 0.030 |
Why?
|
Social Class | 1 | 2024 | 2007 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2024 | 1219 | 0.030 |
Why?
|
Pharmaceutical Preparations | 1 | 2023 | 1084 | 0.030 |
Why?
|
Colonoscopy | 1 | 2023 | 1406 | 0.030 |
Why?
|
Linear Models | 1 | 2024 | 5876 | 0.030 |
Why?
|
Prevalence | 2 | 2023 | 15842 | 0.030 |
Why?
|
Specialization | 1 | 2019 | 777 | 0.030 |
Why?
|
Reoperation | 1 | 2024 | 4294 | 0.030 |
Why?
|
Angiogenesis Inhibitors | 1 | 2024 | 2056 | 0.030 |
Why?
|
Coronary Artery Bypass | 1 | 2023 | 2186 | 0.030 |
Why?
|
Disease Management | 1 | 2024 | 2535 | 0.030 |
Why?
|
Incidence | 2 | 2023 | 21480 | 0.030 |
Why?
|
Cerebral Hemorrhage | 1 | 2024 | 2648 | 0.030 |
Why?
|
Acute Disease | 1 | 2023 | 7232 | 0.030 |
Why?
|
Anxiety Disorders | 1 | 2023 | 2737 | 0.020 |
Why?
|
Weight Loss | 1 | 2023 | 2710 | 0.020 |
Why?
|
Adolescent | 2 | 2019 | 88835 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3850 | 0.020 |
Why?
|
Echocardiography | 1 | 2024 | 5045 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3110 | 0.020 |
Why?
|
Sex Factors | 1 | 2024 | 10603 | 0.020 |
Why?
|
Health Personnel | 1 | 2023 | 3390 | 0.020 |
Why?
|
Stroke Volume | 1 | 2024 | 5596 | 0.020 |
Why?
|
Diagnostic Imaging | 1 | 2024 | 3529 | 0.020 |
Why?
|
Animals | 2 | 2024 | 168764 | 0.020 |
Why?
|
Tissue Donors | 1 | 2019 | 2395 | 0.020 |
Why?
|
Young Adult | 1 | 2016 | 59889 | 0.020 |
Why?
|
Opioid-Related Disorders | 1 | 2024 | 2178 | 0.020 |
Why?
|
Comorbidity | 1 | 2024 | 10563 | 0.020 |
Why?
|
Communication | 1 | 2023 | 3916 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2024 | 3413 | 0.020 |
Why?
|
Anxiety | 1 | 2023 | 4671 | 0.020 |
Why?
|
Age Factors | 1 | 2024 | 18380 | 0.020 |
Why?
|
Blood Pressure | 1 | 2023 | 8532 | 0.020 |
Why?
|
Quality Improvement | 1 | 2023 | 3853 | 0.020 |
Why?
|
Clinical Trials as Topic | 1 | 2023 | 8041 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2024 | 5891 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2023 | 9249 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20124 | 0.020 |
Why?
|
Child | 2 | 2023 | 80564 | 0.020 |
Why?
|
Quality of Life | 1 | 2023 | 13462 | 0.010 |
Why?
|
Heart Failure | 1 | 2024 | 11840 | 0.010 |
Why?
|